UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alterations in T cell receptor and signal transduction molecules in melanoma patients

Clinical cancer research, 1995-11, Vol.1 (11), p.1327-1335

1995

Volltextzugriff (PDF)

Initial cohort expansion results of sustained arginine depletion with pegzilarginase in melanoma patients in a phase I advanced solid tumor trial

Annals of oncology, 2018-10, Vol.29, p.viii453-viii453

2018

Volltextzugriff (PDF)

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii732-viii732

2018

Volltextzugriff (PDF)

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2752-2760

1998

Volltextzugriff (PDF)

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1141-1152

1992

Volltextzugriff (PDF)

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Science translational medicine, 2012-06, Vol.4 (137), p.137ra74

2012

Volltextzugriff (PDF)

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients : changes during treatment

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (10), p.2204-2207

1993

Volltextzugriff (PDF)

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

The New England journal of medicine, 1993-03, Vol.328 (11), p.756-761

1993

Volltextzugriff (PDF)

Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus

American journal of clinical pathology, 1998, Vol.109 (1), p.90-95

1998

Volltextzugriff (PDF)

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Blood, 1999-05, Vol.93 (10), p.3250-3258

1999

Volltextzugriff (PDF)

Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

Clinical immunology (Orlando, Fla.), 1999-12, Vol.93 (3), p.209-221

1999

Volltextzugriff (PDF)

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity

Blood, 1997-04, Vol.89 (7), p.2529-2536

1997

Volltextzugriff (PDF)

Renal cell carcinoma

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.97

Curti, Brendan D

2004

Volltextzugriff (PDF)

Forum on Charlotte Cotton, "Photography is magic"

Lebenswelt (Milano), 2016-12 (9)

ed. by C. Spenuso, with C. Cotton, O. Meo, A.-K. Rastenberger, D. Curti, B. Burbridge

2016

Volltextzugriff (PDF)

Phase II Trial of Interleukin 1α and Indomethacin in Treatment of Metastatic Melanoma

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (1), p.44-49

1996

Volltextzugriff (PDF)

Physical barriers to drug delivery in tumors

Critical reviews in oncology/hematology, 1993-02, Vol.14 (1), p.29-39

Curti, Brendan D.

1993

Volltextzugriff (PDF)

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2

Journal of clinical oncology, 1993-04, Vol.11 (4), p.652-660

1993

Volltextzugriff (PDF)

LBA40Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1269PInitial cohort expansion results of sustained arginine depletion with pegzilarginase in melanoma patients in a phase I advanced solid tumor trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients

Journal of immunotherapy (1997), 1996-07, Vol.19 (4), p.296-308

1996

Volltextzugriff (PDF)

A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

Journal of immunotherapy (1997), 1996-09, Vol.19 (5), p.364-374

1996

Volltextzugriff (PDF)

Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer

Journal of immunotherapy (1997), 1996-03, Vol.19 (2), p.142-148

1996

Volltextzugriff (PDF)

A phase II study of carboplatin, cisplatin, interferon-α, and tamoxifen for patients with metastatic melanoma

Cancer investigation, 1998, Vol.16 (6), p.374-380

1998

Volltextzugriff (PDF)

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Blood, 2001-04, Vol.97 (7), p.1942-1946

2001

Volltextzugriff (PDF)

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

The cancer journal (Sudbury, Mass.), 2000-05, Vol.6 (3), p.146

2000

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Life Sciences & Biomedicine
(83)
Humans
(72)
Biological And Medical Sciences
(44)
Male
(43)
Female
(39)
Medical Sciences
(37)
Middle Aged
(35)
Oncology
(33)
Adult
(32)
Aged
(27)
Immunotherapy
(23)
Animals
(22)
Pharmacology. Drug Treatments
(18)
Biochemistry & Molecular Biology
(15)
Antineoplastic Agents
(14)
Physical Sciences
(13)
Tumors
(13)
Antineoplastic Agents - Therapeutic Use
(11)
Treatment Outcome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Alterations in T cell receptor and signal transduction molecules in melanoma patients

Initial cohort expansion results of sustained arginine depletion with pegzilarginase in melanoma patients in a phase I advanced solid tumor trial

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients : changes during treatment

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity

Renal cell carcinoma

Forum on Charlotte Cotton, "Photography is magic"

Phase II Trial of Interleukin 1α and Indomethacin in Treatment of Metastatic Melanoma

Physical barriers to drug delivery in tumors

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2

LBA40Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

1269PInitial cohort expansion results of sustained arginine depletion with pegzilarginase in melanoma patients in a phase I advanced solid tumor trial

Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients

A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer

A phase II study of carboplatin, cisplatin, interferon-α, and tamoxifen for patients with metastatic melanoma

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

Suchergebnisse filtern